Skip to main content
. 2017 Sep 13;10(12):381–396. doi: 10.1177/1756285617722500

Figure 1.

Figure 1.

Reductions in Gd-enhancing T1 lesions (a) and newly active T2 lesions (b) in the phase II extension.29,33 Gd, gadolinium; SE, standard error.